Latest News about NRBO
Recent news which mentions NRBO
Stocks That Hit 52-Week Lows On Tuesday
January 25, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
From InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
January 25, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 24, 2022
From Benzinga
From InvestorPlace
28 Stocks Moving in Monday's Pre-Market Session
January 24, 2022
From Benzinga
10 Low-Float Penny Stocks for Steel-Gutted Investors
January 11, 2022
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 06, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
From Benzinga
34 Stocks Moving In Wednesday's Mid-Day Session
January 05, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 05, 2022
From Benzinga
From InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
January 05, 2022
From Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 04, 2022
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
From Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
January 04, 2022
From Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
December 29, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 02, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 14, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 13, 2021
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 13, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
